Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in women with polycystic ovary syndrome undergoing antagonist IVF cycle
IRCT20241225064163N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dexamethasone in female infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Endometrial thickness, Follicle size and 2 more. Started Jan 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20241225064163N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241225064163N1.